Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease

Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease

Abstract Background A three-drug regimen (macrolide, ethambutol, and rifampicin) is recommended for the treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). Although macrolide has proven efficacy, the role of ethambutol and rifampicin in patients without acquired immune deficiency sy...

Full description

Bibliographic Details
Main Authors: Hyung-Jun Kim, Jong Sik Lee, Nakwon Kwak, Jaeyoung Cho, Chang-Hoon Lee, Sung Koo Han, Jae-Joon Yim
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Pulmonary Medicine
Subjects:
Mycobacterium avium complex pulmonary disease
Ethambutol
Rifampicin
Online Access:http://link.springer.com/article/10.1186/s12890-019-0982-8

Similar Items

Similar Items